 ST. LOUIS, Feb. 14, 2022 GLOBE NEWSWIRE -- Stereotaxis NYSE: STXS, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that David Fischel, chairman and CEO, will present at three investor conferences in the first quarter 2022. 